Tag Archives: Alzheimer

FDA Approves New Alzheimer’s Drug That Slows Memory Loss – National

The U.S. Food and Drug Administration on Tuesday approved Eli Lilly’s treatment for early-stage Alzheimer’s disease, the second therapy to slow the progression of the brain disease to become available to U.S. patients. The approval for donanemab, which will be sold under the brand name Kisunla, followed recommendations from the agency’s outside experts who unanimously supported its use in patients …

Read More »

FDA Approves New Alzheimer’s Drug, Offering Hope for Slowing Cognitive Decline

US authorities have approved a new Alzheimer’s drug that may slow the disease somewhat, giving patients in the early stages of the incurable, memory-destroying disease a new option. The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild to early cases of Alzheimer’s dementia. It is only the second drug to be convincingly shown to slow cognitive …

Read More »